Injury guide

UPDATED FEB 2026

PFAS Kidney Cancer Lawsuit

Part of the PFAS Water Contamination investigation

The short answer

Kidney cancer (renal cell carcinoma) is the MDL 2873 Tier 1 bellwether injury — the PFAS-linked condition with the strongest and most consistent epidemiological association. The IARC classified PFOA as a Group 1 known human carcinogen for kidney cancer in 2023.

Individuals who developed kidney cancer after sustained PFAS exposure through drinking water have among the strongest claims in PFAS litigation.

People's Justice Research TeamUpdated February 21, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

The Science Behind PFAS and Kidney Cancer

PFAS accumulate in kidney tissue and disrupt the cellular signaling pathways that control cell growth and death. PFOA and PFOS bind to peroxisome proliferator-activated receptors (PPARs) in kidney cells, altering gene expression in ways that promote tumor formation. PFAS also disrupt the VHL (von Hippel-Lindau) tumor suppressor gene pathway — the same pathway mutated in hereditary kidney cancer — and stimulate angiogenesis (the growth of blood vessels that feed tumors). The C8 Health Project, studying 69,000+ PFOA-exposed individuals in West Virginia and Ohio, found significantly elevated rates of renal cell carcinoma compared to unexposed populations. A 2020 meta-analysis of PFAS epidemiological studies confirmed the association between PFOA exposure and kidney cancer with statistical significance. In 2023, the International Agency for Research on Cancer (IARC) upgraded PFOA to Group 1 — known human carcinogen — with kidney cancer as one of the primary designated cancers.

Kidney Cancer PFAS Claims — What You Need to Prove

For a kidney cancer PFAS claim, you need to establish: (1) Sustained exposure to PFAS-contaminated drinking water — typically 1 or more years of residence near a military base, industrial site, or other confirmed contamination source, or documented use of a contaminated municipal water system or private well; (2) Pathology-confirmed diagnosis of renal cell carcinoma; (3) A medically plausible timeline — kidney cancer typically has a latency period of 5 to 20 years from the time of carcinogen exposure, so a diagnosis several years after the start of PFAS exposure is expected; (4) No other dominant explanation for the kidney cancer (significant independent risk factors like smoking reduce but do not eliminate the PFAS causation argument). An attorney can help obtain water utility testing records, DoD contamination disclosures, and your medical records to build the exposure and causation case. The 2016 Bartlett v. DuPont jury verdict ($5.1 million for PFOA-related kidney cancer) is the bellwether precedent for individual PFAS kidney cancer claims.

Kidney Cancer Treatment and Damages

Renal cell carcinoma treatment depends on stage. Localized RCC (Stage I–II) is typically treated with partial or radical nephrectomy (surgical removal of part or all of the kidney). Advanced RCC (Stage III–IV) requires targeted therapy (sunitinib, pazopanib, cabozantinib), immunotherapy (nivolumab, ipilimumab), or combination regimens. Stage IV RCC has a five-year survival rate of approximately 12%, creating significant wrongful death and future care damages. Economic damages in kidney cancer PFAS claims include all surgical and oncology costs, lifetime monitoring, targeted therapy drug costs (which can exceed $15,000 per month), lost wages, and future earning capacity. Non-economic damages include pain and suffering, loss of kidney function, and the psychological impact of a cancer diagnosis in an individual who had no warning their water supply was contaminated.

Dive deeper

Related Guides

11 GUIDES

The full investigation

Part of the PFAS Water Contamination Investigation